Diaceutics Plc (DXRX) Ord GBP0.002
- Add to watchlist
- Create an alert
- This stock can be held in a
117.50p
117.63p
136.00p
£99.25 million
117.50p
115.00p
84.50p
n/a
1.00p (0.84%) Previous:
1.00p
15,095
n/a
3,000
Performance
Not available for this stock.
Fundamental data
Year ending: | 31/12/2023 | 31/12/2022 |
---|---|---|
Revenue (£m) | 23.70 | 19.50 |
Profit before tax (£m) | (2.44) | 0.56 |
Adjusted EPS (p): | (2.07) | 0.86 |
P/E ratio | n/a | 87.80 |
PEG | n/a | 3.10 |
EPS growth (%) | n/a | 28.00 |
Values are quoted in the stock's local currency: British pound
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
Diaceutics reports progress with rare-disease offerings
27 August 2024 12:24
-
Diaceutics strikes 'groundbreaking' enterprise promotional partnership
19 August 2024 08:11
-
Diaceutics strikes two new enterprise-wide agreements
16 May 2024 10:09
-
Capital Markets Webinar
5 November 2024 07:00
-
Holding(s) in Company
4 November 2024 07:00
-
PDMR Shareholding/Share Incentive Plan
30 October 2024 14:58
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.